Back to GILD

GILEAD SCIENCES, INC. Capital Expenditures 2013-2026 | GILD

Beta

What is capital expenditures?

Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.

What is GILEAD SCIENCES, INC.'s current capital expenditures?

GILEAD SCIENCES, INC. (GILD) annual capital expenditures for 2025 was $563.0M, a 7.65% increase from 2024. GILEAD SCIENCES, INC. capital expenditures for the quarter ending March 31, 2026 was $117.0M.

What was GILEAD SCIENCES, INC.'s capital expenditures in 2024?

GILEAD SCIENCES, INC. annual capital expenditures for 2024 was $523.0M, a 10.60% decline from 2023.

What was GILEAD SCIENCES, INC.'s capital expenditures in 2023?

GILEAD SCIENCES, INC. annual capital expenditures for 2023 was $585.0M, a 19.64% decline from 2022.

What is GILEAD SCIENCES, INC.'s 5-year capital expenditures CAGR?

GILEAD SCIENCES, INC. capital expenditures grew at a compound annual growth rate (CAGR) of 2.83% from FY2020 to FY2025, going from $650.0M to $563.0M over 5 years.

Capital Expenditures History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR-2.8%
FY2020
$650.0M
FY2025
$563.0M
131819202122232425
5 years selected
Capital Expenditures History
PeriodValueChangeSource
FY2025$563.0M+7.6%10-K
FY2024$523.0M-10.6%10-K
FY2023$585.0M-19.6%10-K
FY2022$728.0M+25.7%10-K
FY2021$579.0M-10.9%10-K
FY2020$650.0M-21.2%10-K
FY2019$825.0M-10.7%10-K
FY2018$924.0M+589.6%10-K
FY2013$134.0M-10-K
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →